This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Progyny, Inc.
2/27/2025
Thanks for holding. We appreciate your time and patience. Please stay on the line, and we'll be back in just a moment.
Good day, ladies and gentlemen. Welcome to the Progeny, Inc. Fourth Quarter Earnings Conference Call. At this time, all participants are on a listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, James Hart. The floor is yours.
Thank you, John, and good afternoon, everyone. Welcome to our fourth quarter conference call. With me today are Pete Inefsky, CEO of Progeny, Michael Stermer, President, and Mark Livingston, CFO. We will begin with some prepared remarks before we open the call for your questions. Before we begin, I'll remind you that our comments and responses to your questions today reflect management's views as of today only, and will include statements related to our financial outlook for both the first quarter and full year 2025, and the assumptions and drivers underlying such guidance, including the impact of our sales season and client launches, and our expected utilization rates and mix, our anticipated number of clients and covered lives for 2025, the potential benefits of our solution, our ability to acquire new clients and retain and upsell existing clients, our market opportunity, and our business strategy, plans, goals, and expectations concerning our market position, future operations, and other financial and operating information, which are forward-looking statements under the federal securities law. Actual results may differ materially from those contained in or implied by these forward-looking statements due to risks and uncertainties associated with our business, as well as other important factors. For discussion of the material risks, uncertainties, assumptions, and other important factors that could impact our actual results, please refer to our SEC filing and today's press release, both of which can be found on our investor relations website. Any forward-looking statements that we make on this call are based on assumptions as of today, and we undertake no obligation to update these statements as a result of new information or future events. During the call, we will also refer to non-GAAP financial measures, such as adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA margin on incremental revenue, and non-GAAP earnings per diluted share. More information about these non-GAAP financial measures, including reconciliations with the most comparable GAAP measures, are available in the press release, which is available at investors.progeny.com. I would now like to turn the call over to Pete.
You're reading a preview of the PGNY Q4 2024 earnings call.
Free account.